Lutein and β-Carotene Characterization in Free and Nanodispersion Forms in Terms of Antioxidant Activity and Cytotoxicity

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Nourhan S. Elkholy, Mohamad Louai M. Hariri, Haitham S. Mohammed, Medhat W. Shafaa
{"title":"Lutein and β-Carotene Characterization in Free and Nanodispersion Forms in Terms of Antioxidant Activity and Cytotoxicity","authors":"Nourhan S. Elkholy,&nbsp;Mohamad Louai M. Hariri,&nbsp;Haitham S. Mohammed,&nbsp;Medhat W. Shafaa","doi":"10.1007/s12247-023-09745-2","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Carotenoids are potent natural antioxidants with many important applications. Their nanodispersion formulations can solve problems that may limit their usage. In this study, we produced carotenoid nanodispersions from extracted lutein (nano-Lut), extracted β-carotene (nano-EBc), and synthetic β-carotene (nano-SBC).</p><h3>Methods</h3><p>The present study has quantitatively emphasized the physicochemical, antioxidant, and cytotoxic properties of free and nanodispersed formulations of lutein and β-carotene. The nanodispersions were characterized by spectral absorption, dynamic light scattering, and zeta potential. Antioxidant and cytotoxicity assays were conducted for free and their nanodispersed forms. The cytotoxicity of free carotenoids and their nanodispersions was conducted on HSF, VERO, and BNL cell lines.</p><h3>Results</h3><p>Nano-Lut has the smallest mean particle size (185.2 ± 40.5 nm, PDI of 0.183 ± 0.01, and zeta potential of −28.6 ± 6.4 mV). Nano-SBc showed monomodal size distribution (220.5 ± 30.09 nm, PDI of 0.318 ± 0.03, and zeta potential of −12.1 ± 5.9 mV), while nano-EBc showed a bimodal size distribution (with a mean particle size of 498.3 ± 88.9 nm, PDI of 0.65 ± 0.08, and zeta potential of −39.7 ± 1.3 mV). All prepared nanodispersions showed less than 20% loss during the formulation process. Antioxidant assays showed that extracted lutein was the most active and synthetic β-carotene was the least. Cells showed higher tolerance for lutein and its nanodispersion than extracted or synthetic β-carotene either in free or nanodispersion forms.</p><h3>Conclusions</h3><p>The study proved that lutein in nanodispersed form possesses the smallest size, the highest antioxidant activity, and the lowest cytotoxicity among the tested formulations.\n</p></div>","PeriodicalId":656,"journal":{"name":"Journal of Pharmaceutical Innovation","volume":"18 4","pages":"1727 - 1744"},"PeriodicalIF":2.7000,"publicationDate":"2023-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12247-023-09745-2.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Innovation","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12247-023-09745-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

Carotenoids are potent natural antioxidants with many important applications. Their nanodispersion formulations can solve problems that may limit their usage. In this study, we produced carotenoid nanodispersions from extracted lutein (nano-Lut), extracted β-carotene (nano-EBc), and synthetic β-carotene (nano-SBC).

Methods

The present study has quantitatively emphasized the physicochemical, antioxidant, and cytotoxic properties of free and nanodispersed formulations of lutein and β-carotene. The nanodispersions were characterized by spectral absorption, dynamic light scattering, and zeta potential. Antioxidant and cytotoxicity assays were conducted for free and their nanodispersed forms. The cytotoxicity of free carotenoids and their nanodispersions was conducted on HSF, VERO, and BNL cell lines.

Results

Nano-Lut has the smallest mean particle size (185.2 ± 40.5 nm, PDI of 0.183 ± 0.01, and zeta potential of −28.6 ± 6.4 mV). Nano-SBc showed monomodal size distribution (220.5 ± 30.09 nm, PDI of 0.318 ± 0.03, and zeta potential of −12.1 ± 5.9 mV), while nano-EBc showed a bimodal size distribution (with a mean particle size of 498.3 ± 88.9 nm, PDI of 0.65 ± 0.08, and zeta potential of −39.7 ± 1.3 mV). All prepared nanodispersions showed less than 20% loss during the formulation process. Antioxidant assays showed that extracted lutein was the most active and synthetic β-carotene was the least. Cells showed higher tolerance for lutein and its nanodispersion than extracted or synthetic β-carotene either in free or nanodispersion forms.

Conclusions

The study proved that lutein in nanodispersed form possesses the smallest size, the highest antioxidant activity, and the lowest cytotoxicity among the tested formulations.

Abstract Image

游离和纳米分散形式的叶黄素和β-胡萝卜素的抗氧化活性和细胞毒性表征
目的类胡萝卜素是一种强效天然抗氧化剂,具有许多重要用途。类胡萝卜素的纳米分散制剂可以解决可能限制其应用的问题。本研究从提取的叶黄素(纳米叶黄素)、提取的β-胡萝卜素(纳米β-胡萝卜素)和合成的β-胡萝卜素(纳米β-胡萝卜素)中制备了类胡萝卜素纳米分散体。通过光谱吸收、动态光散射和 Zeta 电位对纳米分散体进行了表征。对游离态和纳米分散态进行了抗氧化和细胞毒性检测。在 HSF、VERO 和 BNL 细胞系上检测了游离类胡萝卜素及其纳米分散体的细胞毒性。结果 纳米-Lut 的平均粒径最小(185.2 ± 40.5 nm,PDI 为 0.183 ± 0.01,zeta 电位为 -28.6 ± 6.4 mV)。纳米 SBc 呈单模粒度分布(220.5 ± 30.09 nm,PDI 为 0.318 ± 0.03,zeta 电位为 -12.1 ± 5.9 mV),而纳米 EBc 呈双模粒度分布(平均粒度为 498.3 ± 88.9 nm,PDI 为 0.65 ± 0.08,zeta 电位为 -39.7 ± 1.3 mV)。所有制备的纳米分散体在配制过程中的损失均小于 20%。抗氧化试验表明,提取的叶黄素活性最高,而合成的β-胡萝卜素活性最低。细胞对叶黄素及其纳米分散体的耐受性高于提取的或合成的β-胡萝卜素,无论是自由形式还是纳米分散体形式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pharmaceutical Innovation
Journal of Pharmaceutical Innovation PHARMACOLOGY & PHARMACY-
CiteScore
3.70
自引率
3.80%
发文量
90
审稿时长
>12 weeks
期刊介绍: The Journal of Pharmaceutical Innovation (JPI), is an international, multidisciplinary peer-reviewed scientific journal dedicated to publishing high quality papers emphasizing innovative research and applied technologies within the pharmaceutical and biotechnology industries. JPI''s goal is to be the premier communication vehicle for the critical body of knowledge that is needed for scientific evolution and technical innovation, from R&D to market. Topics will fall under the following categories: Materials science, Product design, Process design, optimization, automation and control, Facilities; Information management, Regulatory policy and strategy, Supply chain developments , Education and professional development, Journal of Pharmaceutical Innovation publishes four issues a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信